Spero Therapeutics Financial Overview
Spero Therapeutics's market cap is currently $131.27M. The company's EPS TTM is $-0.13; its P/E ratio is -2.93; Spero Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
